全体要約
2023年の世界の嚢胞性線維症膜貫通伝導調節因子モジュレーター市場は、2024年から2030年にかけてのCAGRは%で成長すると予測されています。アメリカ、中国、ヨーロッパの市場も同様に成長が見込まれ、各地域の市場規模は2023年から2030年にかけて増加する見込みです。主要企業には、Vertex Pharmaceuticals、ReCode Therapeutics、Arcturus Therapeutics、AbbVie、Spirovant Sciencesなどが含まれ、2023年には上位2社が市場の%を占めています。
この市場は、製品タイプ（コレクター、ポテンシエーター、アンプリファイア）やアプリケーション（臨床、非臨床）によってセグメント化されており、地域別の詳細な分析も行われています。市場の成長機会や主要トレンドを把握するために、各企業の戦略や市場シェアも評価されています。
関連する質問
Vertex Pharmaceuticals, ReCode Therapeutics, Arcturus Therapeutics, AbbVie, Spirovant Sciences, 4D Molecular Therapeutics
製品セグメンテーションの重要なトレンド, 主要企業の戦略分析, 地域別市場の成長機会
概要
LPI (LP Information)の最新の調査報告書「嚢胞性線維症跨膜コンダクタンス調節因子モジュレーター産業予測」では、過去の販売を調査し、2023年の世界の嚢胞性線維症跨膜コンダクタンス調節因子モジュレーターの総販売をレビューし、2024年から2030年までの予測される販売について、地域別および市場セクター別の包括的な分析を提供。嚢胞性線維症跨膜コンダクタンス調節因子モジュレーターの販売を地域、市場セクター、およびサブセクター別に分けて、この報告書は世界の嚢胞性線維症跨膜コンダクタンス調節因子モジュレーター産業の詳細な分析を百万米ドル単位で提供します。
このインサイトレポートは、世界の嚢胞性線維症トランスメンブレントコンダクタンス調節因子の景観に関する包括的な分析を提供し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発、M&A活動に関連する重要なトレンドを強調しています。このレポートは、嚢胞性線維症トランスメンブレントコンダクタンス調節因子のポートフォリオと能力、市場参入戦略、市場ポジション、地理的展開に焦点を当てながら、世界の主要企業の戦略も分析し、加速する世界の嚢胞性線維症トランスメンブレントコンダクタンス調節因子市場におけるこれらの企業の独自のポジションをより理解するためのものです。
このインサイトレポートは、嚢胞性線維症トランスメンブレン導電調節因子モジュレーターに関する主要な市場動向、ドライバーおよび影響要因を評価し、タイプ、アプリケーション、地理、そして市場規模によって予測を分解し、新たに出現する機会を強調します。何百ものボトムアップによる定性的および定量的市場データに基づいた透明な手法を用いたこの研究の予測は、全球的な嚢胞性線維症トランスメンブレン導電調節因子モジュレーターの現在の状態と将来の軌道に関する非常に詳細な視点を提供します。
アメリカの嚢胞性線維症膜貫通伝導調節因子の市場は、2023年のXX米ドルから2030年にはXX米ドルに増加すると推定されており、2024年から2030年までのCAGRはXX%です。
中国の嚢胞性線維症膜伝導調節因子修飾剤市場は、2023年のXX米ドルから2030年までにXX米ドルに増加すると見込まれています。2024年から2030年までのCAGRはXX%です。
cystic fibrosis 転送調節因子 モジュレーターのヨーロッパ市場は、2023年のXX米ドルから2030年までにXX米ドルに増加すると推定されています。2024年から2030年までのCAGRはXX%です。
グローバルな主要な嚢胞性線維症トランスメンブレン導電調節因子のプレイヤーには、バーテックス・ファーマシューティカルト、リコード・セラピューティクス、アークチュラス・セラピューティクス、アッヴィ、およびスピロバント・サイエンシズなどが含まれます。収益の観点から、2023年には世界の二大企業がほぼXX%のシェアを占めました。
このレポートは、嚢胞性線維症膜貫通伝導調節因子市場の製品タイプ、アプリケーション、主要プレーヤー、主要な地域および国ごとの包括的な概要、市場シェア、成長機会を提示します。
タイプ別セグメンテーション
修正器
ポテンシエーター
アンプ
用途別のセグメンテーション
臨床
非臨床
このレポートは、市場を地域別にも分けています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
下記のプロフィールが紹介されている企業は、一次専門家から収集した情報と企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されました。
バーテックス・ファーマシューティカルズ
ReCodeセラピューティクス
アークチュラス・セラピューティクス
アッヴィ
スピロバント・サイエンシズ
4D分子治療学
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、（2019年～2030年）
2.1.2 嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、CAGR（地域別）（2019年 vs 2023年 vs 2030年）
2.2 嚢胞性線維症膜貫通伝導調節因子モジュレーターセグメント、タイプ別
2.2.1 コレクターズ
2.2.2 ポテンショメーター
2.2.3 アンプ
2.3 嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模：タイプ別
2.3.1 嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、CAGR（タイプ別）（2019年 vs 2023年 vs 2030年）
2.3.2 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、市場シェア（タイプ別）（2019年～2024年）
2.4 嚢胞性線維症膜貫通伝導調節因子モジュレーターセグメント、用途別
2.4.1 クリニカル
2.4.2 ノンクリニカル
2.5 嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模：用途別
2.5.1 嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、CAGR（用途別）（2019年 vs 2023年 vs 2030年）
2.5.2 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、市場シェア（用途別）（2019年～2024年）
3 嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模：プレイヤー別
3.1 嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場の収益規模、プレイヤー別（2019年～2024年）
3.1.2 グローバルにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場の収益シェア、プレイヤー別（2019年～2024年）
3.2 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2022年～2024年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 嚢胞性線維症膜貫通伝導調節因子モジュレーター、地域別
4.1 嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模（地域別）（2019年～2024年）
4.2 アメリカズにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模成長（2019年〜2024年）
4.3 APACにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模成長（2019年〜2024年）
4.4 ヨーロッパにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模成長（2019年〜2024年）
4.5 中東・アフリカにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模成長（2019年〜2024年）
5 アメリカズ
5.1 アメリカズにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、国別（2019年〜2024年）
5.2 アメリカズにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、タイプ別（2019年〜2024年）
5.3 アメリカズにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、用途別（2019年〜2024年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、地域別（2019年〜2024年）
6.2 APACにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、タイプ別（2019年〜2024年）
6.3 APACにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、用途別（2019年〜2024年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの嚢胞性線維症膜貫通伝導調節因子モジュレーター 国別（2019年～2024年）
7.2 ヨーロッパにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、タイプ別（2019年〜2024年）
7.3 ヨーロッパにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、用途別（2019年〜2024年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの嚢胞性線維症膜貫通伝導調節因子モジュレーター 地域別（2019年～2024年）
8.2 中東・アフリカにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、タイプ別（2019年〜2024年）
8.3 中東・アフリカにおける嚢胞性線維症膜貫通伝導調節因子モジュレーター市場規模、用途別（2019年〜2024年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター市場、市場予測
10.1 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測（地域別）（2025年～2030年）
10.1.1 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測（地域別）（2025年～2030年）
10.1.2 アメリカズの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測
10.1.3 APACの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測
10.1.4 ヨーロッパの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測
10.1.5 中東・アフリカの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測
10.2 アメリカズの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測（国別）（2025年～2030年）
10.3 APACの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測（地域別）（2025年～2030年）
10.4 ヨーロッパの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測（国別）（2025年～2030年）
10.5 中東・アフリカの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測（地域別）（2025年～2030年）
10.6 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測（タイプ別）（2025年～2030年）
10.7 グローバルの嚢胞性線維症膜貫通伝導調節因子モジュレーター、市場予測（用途別）（2025年～2030年）
11 キープレイヤー分析
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals：企業情報
11.1.2 Vertex Pharmaceuticals：嚢胞性線維症膜貫通伝導調節因子モジュレーター分野の提供製品
11.1.3 Vertex Pharmaceuticals：嚢胞性線維症膜貫通伝導調節因子モジュレーター収益・グロスマージンおよび市場シェア（2019年～2024年）
11.1.4 Vertex Pharmaceuticals：主要事業概要
11.1.5 Vertex Pharmaceuticals：直近の展開
11.2 ReCode Therapeutics
11.2.1 ReCode Therapeutics：企業情報
11.2.2 ReCode Therapeutics：嚢胞性線維症膜貫通伝導調節因子モジュレーター分野の提供製品
11.2.3 ReCode Therapeutics：嚢胞性線維症膜貫通伝導調節因子モジュレーター収益・グロスマージンおよび市場シェア（2019年～2024年）
11.2.4 ReCode Therapeutics：主要事業概要
11.2.5 ReCode Therapeutics：直近の展開
11.3 Arcturus Therapeutics
11.3.1 Arcturus Therapeutics：企業情報
11.3.2 Arcturus Therapeutics：嚢胞性線維症膜貫通伝導調節因子モジュレーター分野の提供製品
11.3.3 Arcturus Therapeutics：嚢胞性線維症膜貫通伝導調節因子モジュレーター収益・グロスマージンおよび市場シェア（2019年～2024年）
11.3.4 Arcturus Therapeutics：主要事業概要
11.3.5 Arcturus Therapeutics：直近の展開
11.4 AbbVie
11.4.1 AbbVie：企業情報
11.4.2 AbbVie：嚢胞性線維症膜貫通伝導調節因子モジュレーター分野の提供製品
11.4.3 AbbVie：嚢胞性線維症膜貫通伝導調節因子モジュレーター収益・グロスマージンおよび市場シェア（2019年～2024年）
11.4.4 AbbVie：主要事業概要
11.4.5 AbbVie：直近の展開
11.5 Spirovant Sciences
11.5.1 Spirovant Sciences：企業情報
11.5.2 Spirovant Sciences：嚢胞性線維症膜貫通伝導調節因子モジュレーター分野の提供製品
11.5.3 Spirovant Sciences：嚢胞性線維症膜貫通伝導調節因子モジュレーター収益・グロスマージンおよび市場シェア（2019年～2024年）
11.5.4 Spirovant Sciences：主要事業概要
11.5.5 Spirovant Sciences：直近の展開
11.6 4D Molecular Therapeutics
11.6.1 4D Molecular Therapeutics：企業情報
11.6.2 4D Molecular Therapeutics：嚢胞性線維症膜貫通伝導調節因子モジュレーター分野の提供製品
11.6.3 4D Molecular Therapeutics：嚢胞性線維症膜貫通伝導調節因子モジュレーター収益・グロスマージンおよび市場シェア（2019年～2024年）
11.6.4 4D Molecular Therapeutics：主要事業概要
11.6.5 4D Molecular Therapeutics：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Cystic Fibrosis Transmembrane Conductance Regulator Modulator Industry Forecast” looks at past sales and reviews total world Cystic Fibrosis Transmembrane Conductance Regulator Modulator sales in 2023, providing a comprehensive analysis by region and market sector of projected Cystic Fibrosis Transmembrane Conductance Regulator Modulator sales for 2024 through 2030. With Cystic Fibrosis Transmembrane Conductance Regulator Modulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cystic Fibrosis Transmembrane Conductance Regulator Modulator industry.
This Insight Report provides a comprehensive analysis of the global Cystic Fibrosis Transmembrane Conductance Regulator Modulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cystic Fibrosis Transmembrane Conductance Regulator Modulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cystic Fibrosis Transmembrane Conductance Regulator Modulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cystic Fibrosis Transmembrane Conductance Regulator Modulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cystic Fibrosis Transmembrane Conductance Regulator Modulator.
United States market for Cystic Fibrosis Transmembrane Conductance Regulator Modulator is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Cystic Fibrosis Transmembrane Conductance Regulator Modulator is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Cystic Fibrosis Transmembrane Conductance Regulator Modulator is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Cystic Fibrosis Transmembrane Conductance Regulator Modulator players cover Vertex Pharmaceuticals, ReCode Therapeutics, Arcturus Therapeutics, AbbVie and Spirovant Sciences and etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystic Fibrosis Transmembrane Conductance Regulator Modulator market by product type, application, key players and key regions and countries.
Segmentation by type
Correctors
Potentiators
Amplifiers
Segmentation by application
Clinical
Non-clinical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Vertex Pharmaceuticals
ReCode Therapeutics
Arcturus Therapeutics
AbbVie
Spirovant Sciences
4D Molecular Therapeutics
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2019-2030
2.1.2 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Segment by Type
2.2.1 Correctors
2.2.2 Potentiators
2.2.3 Amplifiers
2.3 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type
2.3.1 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type (2019-2024)
2.4 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Segment by Application
2.4.1 Clinical
2.4.2 Non-clinical
2.5 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application
2.5.1 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application (2019-2024)
3 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Player
3.1 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Players
3.1.1 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue by Players (2019-2024)
3.1.2 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue Market Share by Players (2019-2024)
3.2 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cystic Fibrosis Transmembrane Conductance Regulator Modulator by Regions
4.1 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Regions (2019-2024)
4.2 Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth (2019-2024)
4.3 APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth (2019-2024)
4.4 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth (2019-2024)
4.5 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth (2019-2024)
5 Americas
5.1 Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Country (2019-2024)
5.2 Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024)
5.3 Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Region (2019-2024)
6.2 APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024)
6.3 APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator by Country (2019-2024)
7.2 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024)
7.3 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator by Region (2019-2024)
8.2 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024)
8.3 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.1 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast by Regions (2025-2030)
10.1.1 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast by Regions (2025-2030)
10.1.2 Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast
10.1.3 APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast
10.1.4 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast
10.1.5 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast
10.2 Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast by Country (2025-2030)
10.2.1 United States Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.2.2 Canada Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.2.3 Mexico Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.2.4 Brazil Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.3 APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast by Region (2025-2030)
10.3.1 China Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.3.2 Japan Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.3.3 Korea Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.3.4 Southeast Asia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.3.5 India Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.3.6 Australia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.4 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast by Country (2025-2030)
10.4.1 Germany Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.4.2 France Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.4.3 UK Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.4.4 Italy Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.4.5 Russia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.5 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast by Region (2025-2030)
10.5.1 Egypt Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.5.2 South Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.5.3 Israel Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.5.4 Turkey Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.5.5 GCC Countries Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast
10.6 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast by Type (2025-2030)
10.7 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Information
11.1.2 Vertex Pharmaceuticals Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered
11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Vertex Pharmaceuticals Main Business Overview
11.1.5 Vertex Pharmaceuticals Latest Developments
11.2 ReCode Therapeutics
11.2.1 ReCode Therapeutics Company Information
11.2.2 ReCode Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered
11.2.3 ReCode Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 ReCode Therapeutics Main Business Overview
11.2.5 ReCode Therapeutics Latest Developments
11.3 Arcturus Therapeutics
11.3.1 Arcturus Therapeutics Company Information
11.3.2 Arcturus Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered
11.3.3 Arcturus Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Arcturus Therapeutics Main Business Overview
11.3.5 Arcturus Therapeutics Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered
11.4.3 AbbVie Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Spirovant Sciences
11.5.1 Spirovant Sciences Company Information
11.5.2 Spirovant Sciences Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered
11.5.3 Spirovant Sciences Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Spirovant Sciences Main Business Overview
11.5.5 Spirovant Sciences Latest Developments
11.6 4D Molecular Therapeutics
11.6.1 4D Molecular Therapeutics Company Information
11.6.2 4D Molecular Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered
11.6.3 4D Molecular Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 4D Molecular Therapeutics Main Business Overview
11.6.5 4D Molecular Therapeutics Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Correctors Table 3. Major Players of Potentiators Table 4. Major Players of Amplifiers Table 5. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 6. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024) & ($ Millions) Table 7. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type (2019-2024) Table 8. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 9. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024) & ($ Millions) Table 10. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application (2019-2024) Table 11. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue by Players (2019-2024) & ($ Millions) Table 12. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue Market Share by Player (2019-2024) Table 13. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Key Players Head office and Products Offered Table 14. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Regions 2019-2024 & ($ Millions) Table 18. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Regions (2019-2024) Table 19. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue by Country/Region (2019-2024) & ($ millions) Table 20. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue Market Share by Country/Region (2019-2024) Table 21. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Country (2019-2024) & ($ Millions) Table 22. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Country (2019-2024) Table 23. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024) & ($ Millions) Table 24. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type (2019-2024) Table 25. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024) & ($ Millions) Table 26. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application (2019-2024) Table 27. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Region (2019-2024) & ($ Millions) Table 28. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Region (2019-2024) Table 29. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024) & ($ Millions) Table 30. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type (2019-2024) Table 31. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024) & ($ Millions) Table 32. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application (2019-2024) Table 33. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Country (2019-2024) & ($ Millions) Table 34. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Country (2019-2024) Table 35. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024) & ($ Millions) Table 36. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type (2019-2024) Table 37. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024) & ($ Millions) Table 38. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application (2019-2024) Table 39. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Region (2019-2024) & ($ Millions) Table 40. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Region (2019-2024) Table 41. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type (2019-2024) & ($ Millions) Table 42. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type (2019-2024) Table 43. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2019-2024) & ($ Millions) Table 44. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application (2019-2024) Table 45. Key Market Drivers & Growth Opportunities of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Table 46. Key Market Challenges & Risks of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Table 47. Key Industry Trends of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Table 48. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 49. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share Forecast by Regions (2025-2030) Table 50. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Forecast by Type (2025-2030) & ($ Millions) Table 51. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Forecast by Application (2025-2030) & ($ Millions) Table 52. Vertex Pharmaceuticals Details, Company Type, Cystic Fibrosis Transmembrane Conductance Regulator Modulator Area Served and Its Competitors Table 53. Vertex Pharmaceuticals Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered Table 54. Vertex Pharmaceuticals Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 55. Vertex Pharmaceuticals Main Business Table 56. Vertex Pharmaceuticals Latest Developments Table 57. ReCode Therapeutics Details, Company Type, Cystic Fibrosis Transmembrane Conductance Regulator Modulator Area Served and Its Competitors Table 58. ReCode Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered Table 59. ReCode Therapeutics Main Business Table 60. ReCode Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 61. ReCode Therapeutics Latest Developments Table 62. Arcturus Therapeutics Details, Company Type, Cystic Fibrosis Transmembrane Conductance Regulator Modulator Area Served and Its Competitors Table 63. Arcturus Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered Table 64. Arcturus Therapeutics Main Business Table 65. Arcturus Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 66. Arcturus Therapeutics Latest Developments Table 67. AbbVie Details, Company Type, Cystic Fibrosis Transmembrane Conductance Regulator Modulator Area Served and Its Competitors Table 68. AbbVie Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered Table 69. AbbVie Main Business Table 70. AbbVie Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 71. AbbVie Latest Developments Table 72. Spirovant Sciences Details, Company Type, Cystic Fibrosis Transmembrane Conductance Regulator Modulator Area Served and Its Competitors Table 73. Spirovant Sciences Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered Table 74. Spirovant Sciences Main Business Table 75. Spirovant Sciences Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 76. Spirovant Sciences Latest Developments Table 77. 4D Molecular Therapeutics Details, Company Type, Cystic Fibrosis Transmembrane Conductance Regulator Modulator Area Served and Its Competitors Table 78. 4D Molecular Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product Offered Table 79. 4D Molecular Therapeutics Main Business Table 80. 4D Molecular Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 81. 4D Molecular Therapeutics Latest Developments List of Figures Figure 1. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Sales Market Share by Country/Region (2023) Figure 8. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type in 2023 Figure 10. Cystic Fibrosis Transmembrane Conductance Regulator Modulator in Clinical Figure 11. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market: Clinical (2019-2024) & ($ Millions) Figure 12. Cystic Fibrosis Transmembrane Conductance Regulator Modulator in Non-clinical Figure 13. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market: Non-clinical (2019-2024) & ($ Millions) Figure 14. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application in 2023 Figure 15. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue Market Share by Player in 2023 Figure 16. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Regions (2019-2024) Figure 17. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2019-2024 ($ Millions) Figure 18. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2019-2024 ($ Millions) Figure 19. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2019-2024 ($ Millions) Figure 20. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2019-2024 ($ Millions) Figure 21. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Value Market Share by Country in 2023 Figure 22. United States Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 23. Canada Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 24. Mexico Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 25. Brazil Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 26. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Region in 2023 Figure 27. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type in 2023 Figure 28. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application in 2023 Figure 29. China Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 30. Japan Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 31. Korea Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 32. Southeast Asia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 33. India Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 34. Australia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 35. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Country in 2023 Figure 36. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type (2019-2024) Figure 37. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application (2019-2024) Figure 38. Germany Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 39. France Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 40. UK Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 41. Italy Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 42. Russia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 43. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Region (2019-2024) Figure 44. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Type (2019-2024) Figure 45. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share by Application (2019-2024) Figure 46. Egypt Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 47. South Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 48. Israel Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 49. Turkey Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 50. GCC Country Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Growth 2019-2024 ($ Millions) Figure 51. Americas Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 52. APAC Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 53. Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 54. Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 55. United States Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 56. Canada Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 57. Mexico Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 58. Brazil Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 59. China Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 60. Japan Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 61. Korea Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 62. Southeast Asia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 63. India Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 64. Australia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 65. Germany Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 66. France Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 67. UK Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 68. Italy Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 69. Russia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 70. Spain Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 71. Egypt Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 72. South Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 73. Israel Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 74. Turkey Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 75. GCC Countries Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size 2025-2030 ($ Millions) Figure 76. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share Forecast by Type (2025-2030) Figure 77. Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size Market Share Forecast by Application (2025-2030)
